Skip to primary navigation Skip to main content
0 item $0.00

Atherothrombosis and Vascular Biology

Read more

Laboratory head

i Profile of author

Latest Achievements

RT Hall Prize for outstanding achievements in cardiovascular research (2014)

Ross Hohnen Award for the best research application, National Heart Foundation (2012)

World Congress of Cardiology Fellowship Award, National Heart Foundation of Australia (2005)

Schwarz-Monheim-Prize of the German Society of Angiology (2000)

Principal Research Fellow, National Health and Medical Research Council of Australia (2014)

Read full biography
Professor Karlheinz Peter NHMRC L3 Investigator
Developing advanced biotechnological tools for molecular imaging and innovative therapy of atherosclerosis, thrombosis and inflammation.



Dr Justin Cole Ms Habiba Danish Dr Nalin Dayawansa Ms Najma Fithri Ms Samantha Loong Ms Zhengyuan Liu Dr Jath Palasubramaniam Ms Runali Patil Ms Shania Anggita Prijaya Mr Abhishek Roy Ms Julia Skoraczynski Dr Hannah Stevens Dr Abbey Willcox Dr Wen-Kai Wong

Consulting scientist

Professor Geoff Pietersz


About the Atherothrombosis and Vascular Biology laboratory

The Atherothrombosis and Vascular Biology laboratory pursues a broad range of projects that have the common focus on improving diagnosis and therapy of thrombotic and inflammatory diseases such as myocardial infarction and atherosclerosis. A range of biotechnological methods are used, including recombinant protein design/production, generation of functionalised nanoparticles/lipsomes/microbubbles, cell culture, flow cytometry, flow chamber, microfluidics, intravital microscopy, ultrasound, MRI, PET various fluorescence imaging systems and various animal models of thrombosis, atherosclerosis and inflammation. Most recently we have extended our research based on the successful application of our biotechnological tools for the targeting of activated platelets towards diagnosis and therapy of autoimmune diseases, such as multiple sclerosis, and cancer. All of these projects have a strong translational orientation, which is facilitated by several laboratory members (physicians/cardiologists/haematologists) treating patients with cardiovascular and haematological diseases as well as cancer. Several of the research projects resulted in patents that are currently being further translated to ultimately improve the health of patients.

Work in the laboratory is particularly attractive for students and postdoctoral researchers who are interested in the development of advanced biotechnological tools for molecular imaging and novel therapeutics (e.g. nanoparticles and anti-inflammatory drugs for plaque stabilisation). The translational direction of the laboratory and the inclusion of patients in studies is highly attractive for physician scientists.

Research focus

  • Molecular imaging of thrombosis and inflammation using MRI, PET, ultrasound, FLECT, IVIS.
  • Novel recombinant therapeutics for thrombotic and inflammatory diseases.
  • Microfluidic flow chambers.
  • Intravital microscopy.
  • Flow cytometry.
  • Animal models of thrombosis and inflammation.
  • Production of recombinant proteins for diagnosis and therapy.
  • Diagnosis and treatment of patients with coronary artery disease and myocardial infarction.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more